Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 45 results.
User Information
Export Records
  1. 1.   Systematic characterization of multi-omics landscape between gut microbial metabolites and GPCRome in Alzheimer's disease
  2. Qiu, Yunguang; Hou, Yuan; Gohel, Dhruv; Zhou, Yadi; Xu, Jielin; Bykova, Marina; Yang, Yuxin; Leverenz, James B; Pieper, Andrew A; Nussinov,Ruth; Caldwell, Jessica Z K; Brown, J Mark; Cheng, Feixiong
  3. Cell Reports. 2024, Apr 21; 43(5): 114128.
  1. 2.   Orphan G-Protein Coupled Receptor GPRC5B Is Critical for Lymphatic Development
  2. Xu, Wenjing; Nelson-Maney, Nathan P; Bálint, László; Kwon, Hyouk-Bum; Davis, Reema B; Dy, Danielle C M; Dunleavey, James M; St Croix,Brad; Caron, Kathleen M
  3. International Journal of Molecular Sciences. 2022, May 20; 23(10):
  1. 3.   Kaposi sarcoma
  2. Cesarman, Ethel; Damania, Blossom; Krown, Susan E.; Martin, Jeffrey; Bower, Mark; Whitby,Denise
  3. NATURE REVIEWS DISEASE PRIMERS. 2019, Jan 31; 5(1):
  1. 4.   Proteolytically released Lasso/teneurin-2 induces axonal attraction by interacting with latrophilin-1 on axonal growth cones
  2. Vysokov, Nickolai V.; Silva, John-Paul; Lelianova, Vera G.; Suckling, Jason; Cassidy, John; Blackburn, Jennifer K.; Yankova, Natalia; Djamgoz, Mustafa B. A.; Kozlov,Serguei; Tonevitsky, Alexander G.; Ushkaryov, Yuri A.
  3. ELIFE. 2018, NOV 20; 7: pii: e37935..
  1. 5.   Regulation of inflammation by members of the formyl-peptide receptor family
  2. Chen, Keqiang; Bao, Zhiyao; Gong, Wang; Tang, Peng; Yoshimura, Teizo; Wang, Jiming
  3. JOURNAL OF AUTOIMMUNITY. 2017, DEC; 85: 64-77.
  1. 6.   Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma
  2. Uldrick, T. S.; Whitby, D.
  3. Cancer Letters. 2011, Jun; 305(2): 150-162.
  1. 7.   Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); Two multifunctional receptors with unusual properties
  2. Yoshimura, T.; Oppenheim, J. J.
  3. Experimental Cell Research. 2011, Mar; 317(5): 674-684.
  1. 8.   Nedd4 mediates agonist-dependent ubiquitination, lysosomal targeting, and degradation of the beta(2)-adrenergic receptor
  2. Shenoy, S. K.; Xiao, K. H.; Venkataramanan, V.; Snyder, P. M.; Freedman, N. J.; Weissman, A. M.
  3. Journal of Biological Chemistry. 2008 283(32): 22166-22176.
  1. 9.   Large-scale, saturating insertional mutagenesis of the mouse genome
  2. Gragerov, A.; Horie, K.; Pavlova, M.; Madisen, L.; Zeng, H.; Gragerova, G.; Rhode, A.; Dolka, I.; Roth, P.; Ebbert, A.; Moe, S.; Navas, C.; Finn, E.; Bergmann, J.; Vassilatis, D. K.; Pavlakis, G. N.; Gaitanaris, G. A.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2007, Sep; 104(36): 14406-14411.
  1. 10.   Associations of classic Kaposi sarcoma with common variants in genes that modulate host immunity
  2. Brown, E. E.; Fallin, D.; Ruczinski, I.; Hutchinson, A.; Staats, B.; Vitale, F.; Lauria, C.; Serraino, D.; Rezza, G.; Mbisa, G.; Whitby, D.; Messina, A.; Goedert, J. J.; Chanock, S. J.; Kaposi Sarcoma Working, G.
  3. Cancer Epidemiology Biomarkers & Prevention. 2006, May; 15(5): 926-934.
  1. 11.   Host immunogenetics and control of human herpesvirus-8 infection
  2. Brown, E. E.; Fallin, M. D.; Goedert, J. J.; Hutchinson, A.; Vitale, F.; Lauria, C.; Giuliani, M.; Marshall, V.; Mbisa, G.; Serraino, D.; Messina, A.; Durum, S.; Whitby, D.; Chanock, S. J.; Kaposi Sarcoma Genetics Working Group
  3. Journal of Infectious Diseases. 2006, Apr; 193(8): 1054-1062.
  1. 12.   Crosstalk between chemokines and neuronal receptors bridges immune and nervous systems
  2. Zhang, N.; Oppenheim, J. J.
  3. Journal of Leukocyte Biology. 2005, DEC; 78(6): 1210-1214.
  1. 13.   CpG-containing oligodeoxynucleotide promotes microglial cell uptake of amyloid beta 1-42 peptide by up-regulating the expression of the G-protein-coupled receptor mFPR2
  2. Iribarren, P.; Chen, K. Q.; Hu, J. Y.; Gong, W. H.; Cho, E. H.; Lockett, S.; Uranchimeg, B.; Wang, J. M.
  3. Faseb Journal. 2005, OCT; 19(12): Published as FJ Express article on October 11, 2005.
  1. 14.   Formylpeptide receptor FPR and the rapid growth of malignant human gliomas
  2. Zhou, Y.; Bian, X. W.; Le, Y. Y.; Gong, W. H.; Hu, J. Y.; Zhang, X.; Wang, L. H.; Iribarren, P.; Salcedo, R.; Howard, O. M. Z.; Farrar, W.; Wang, J. M.
  3. Journal of the National Cancer Institute. 2005, JUN 1; 97(11): 823-835.
  1. 15.   Identification of functional domains in the formyl peptide receptor-like 1 for agonist-induced cell chemotaxis
  2. Le, Y. Y.; Ye, R. D.; Gong, W. H.; Li, J. X.; Iribarren, P.; Wang, J. M.
  3. Febs Journal. 2005, FEB; 272(3): 769-778.
  1. 16.   Marked structural and functional heterogeneity in CXCR4: Separation of HIV-1 and SDF-I alpha responses
  2. Sloane, A. J.; Raso, V.; Dimitrov, D. S.; Xiao, X. D.; Deo, S.; Muljadi, N.; Restuccia, D.; Turville, S.; Kearney, C.; Broder, C. C.; Zoellner, H.; Cunningham, A. L.; Bendall, L.; Lynch, G. W.
  3. Immunology and Cell Biology. 2005 83(2): 129-143.
  1. 17.   Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in Alzheimer disease
  2. Iribarren, P.; Zhou, Y.; Hu, J. Y.; Le, Y. Y.; Wang, J. M.
  3. Immunologic Research. 2005 31(3): 165-176.
  1. 18.   Silencing the formylpeptide receptor FPR by short-interfering RNA
  2. Le, Y. Y.; Iribarren, P.; Zhou, Y.; Gong, W. H.; Hu, J. Y.; Zhang, X.; Wang, J. M.
  3. Molecular Pharmacology. 2004, OCT; 66(4): 1022-1028.
  1. 19.   The neutrophil granule protein Cathepsin G is a chemotactic agonist for the G protein coupled formyl peptide receptor FPR
  2. Wang, J. M.; Sun, R. H.; Iribarren, P.; Zhang, N.; Zhou, Y.; Gong, W. H.; Cho, E. H.; Lockett, S.; Chertov, O.; Bednar, F.; Rogers, T. J.; Oppenheim, J. J.
  3. Journal of Leukocyte Biology. 2004 (Suppl. S): 24-24.
  1. 20.   Tumor endothelial markers: new targets for cancer therapy
  2. Nanda, A.; St Croix, B.
  3. Current Opinion in Oncology. 2004, JAN; 16(1): 44-49.
  1. 21.   An expanding appreciation of the role chemokine receptors play in cancer progression
  2. Howard, O. M. Z.; Galligan, C. L.
  3. Current Pharmaceutical Design. 2004 10(19): 2377-2389.
  1. 22.   Chemotaxis and calcium responses of phagocytes to formyl peptide receptor ligands is differentially regulated by cyclic ADP ribose
  2. Partida-Sanchez, S.; Iribarren, P.; Moreno-Garcia, M. E.; Gao, X. L.; Murphy, P. M.; Oppenheimer, N.; Wang, J. M.; Lund, F. E.
  3. Journal of Immunology. 2004 172(3): 1896-1906.
  1. 23.   Humanin, a newly identified neuroprotective factor, uses the g protein-coupled formylpeptide receptor-like-1 as a functional receptor
  2. Ying, G. G.; Iribarren, P.; Zhou, Y.; Gong, W. H.; Zhang, N.; Yu, Z. X.; Le, Y.; Cui, Y.; Wang, J. M.
  3. Journal of Immunology. 2004 172(11): 7078-7085.
  1. 24.   Identification of neutrophil granule protein cathepsin G as a novel chemotactic agonist for the G protein-coupled formyl peptide receptor
  2. Sun, R. H.; Iribarren, P.; Zhang, N.; Zhou, Y.; Gong, W. H.; Cho, E. H.; Lockett, S.; Chertov, O.; Bednar, F.; Rogers, T. J.; Oppenheim, J. J.; Wang, J. M.
  3. Journal of Immunology. 2004 173(1): 428-436.
  1. 25.   A high-throughput screen for identification of molecular mimics of Smac/DIABLO utilizing a fluorescence polarization assay
  2. Glover, C. J.; Hite, K.; DeLosh, R.; Scudiero, D. A.; Fivash, M. J.; Smith, L. R.; Fisher, R. J.; Wu, J. W.; Shi, Y. G.; Kipp, R. A.; McLendon, G. L.; Sausville, E. A.; Shoemaker, R. H.
  3. Analytical Biochemistry. 2003 320(2): 157-169.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel